T. Bush, E. Barrett-Connor, L. Cowan, M. Criqui, R. Wallace, C. Suchindran, H. Tyroler, B. Rifkind (1987)
Cardiovascular mortality and noncontraceptive use of estrogen in women: results from the Lipid Research Clinics Program Follow-up Study.Circulation, 75 6
W. Lagrand, C. Visser, W. Hermens, H. Niessen, F. Verheugt, G. Wolbink, C. Hack (1999)
C-reactive protein as a cardiovascular risk factor: more than an epiphenomenon?Circulation, 100 1
Bush (1990)
Non-contraceptive estrogen use and risk of cardiovascular disease, Vol. 18
Grodstein (1999)
Postmenopusal hormones and recurrence of coronary events in the Nurses’ Health StudyCirculation, 100
P. Collins, G. Rosano, P. Sarrel, L. Ulrich, S. Adamopoulos, C. Beale, J. McNeill, P. Poole‐Wilson (1995)
17β-Estradiol Attenuates Acetylcholine-Induced Coronary Arterial Constriction in Women but Not Men With Coronary Heart DiseaseCirculation, 92
George Buren, D. Yang, Kenneth Clark (1992)
Estrogen-induced uterine vasodilatation is antagonized by L-nitroarginine methyl ester, an inhibitor of nitric oxide synthesis.American journal of obstetrics and gynecology, 167 3
M. Cushman, C. Legault, E. Barrett-Connor, M. Stefanick, Craig Kessler, H. Judd, P. Sakkinen, R. Tracy (1999)
Effect of postmenopausal hormones on inflammation-sensitive proteins: the Postmenopausal Estrogen/Progestin Interventions (PEPI) Study.Circulation, 100 7
A. Estellés, A. Cano, C. Falcó, F. España, J. Gilabert, S. Grancha, J. Aznar (1999)
Lipoprotein(a) Levels and Isoforms and Fibrinolytic Activity in Postmenopause – Influence of Hormone Replacement TherapyThrombosis and Haemostasis, 81
Bernd Jilma, Eva Dirnberger, Isabella Löscher, Anna Rumplmayr, Jörg Hildebrandt, Hans-Georg Eichler, Stylianos Kapiotis, Oswald Wagner (1997)
Menstrual cycle-associated changes in blood levels of interleukin-6, alpha1 acid glycoprotein, and C-reactive protein.The Journal of laboratory and clinical medicine, 130 1
J. Heinrich, M. Sandkamp, R. Kokott, H. Schulte, G. Assmann (1991)
Relationship of lipoprotein(a) to variables of coagulation and fibrinolysis in a healthy population.Clinical chemistry, 37 11
N. Wenger, L. Speroff, B. Packard (1993)
Cardiovascular health and disease in women.The New England journal of medicine, 329 4
V. Mijatovic, P. Kenemans, J. Netelenbos, E. Peters-Muller, G. Kamp, G. Voetberg, P. Weijer, M. Mooren (1997)
Oral 17β-Estradiol Continuously Combined with Dydrogesterone Lowers Serum Lipoprotein(a) Concentrations in Healthy Postmenopausal Women1The Journal of Clinical Endocrinology and Metabolism, 82
V. Miller, J. Larosa, V. Barnabei, C. Kessler, G. Levin, Ann Smith-Roth, Margaret Griffin, D. Stoy, T. Bush, H. Zacur, D. Foster, Jean Anderson, A. McKenzie, S. Miller, P. Wood, M. Stefanick, R. Marcus, Allison Akana, W. Heinrichs, C. Kirchner, K. O'Hanlan, M. Ruyle, Mary Sheehan, H. Judd, G. Greendale, Richard Bayalos, K. Lozano, K. Kawakami, E. Barrett-Connor, R. Langer, D. Kritz-Silverstein, M. Carrion-Petersen, C. Cavero, H. Schrott, Susan Johnson, D. Feddersen, Denise Krutzfeldt, J. Benda, C. Pauerstein, J. Trabal, R. Schenken, M. Stern, Mercedes Rodriguez-Sifuentes, Carann Easton, Wells Hb, M. Espeland, G. Howard, R. Byington, C. Legault, S. Shumaker, P. Hogan, D. Hire, C. Wasilauskas, M. James, Kathy Lane, Tim Terrell, S. Reece, J. Pierce, Megan Snow, S. Anthony, Irma Mebane-Sims, P. Einhorn, S. Hunsberger, M. Waclawiw, K. Lippel, D. Lucas, J. Verter, S. Jackson, J. Kelaghan, J. Perlman, P. Wolf, J. McGowan, Stephen Gordon, S. Heyse, J. Fradkin, S. Sherman, L. Page, Annemette Sorenson, B. Hulka, B. Brody, R. Burkman, R. Heaney, R. Krauss, H. Roberts, J. Wittes, L. Riggs, Richards Moss, J. Albers, S. Marcovina, S. Fineberg, R. Tracy, M. Merino, R. Scully, V. Livolsi, G. Kessler (1995)
Effects of Estrogen or Estrogen/ Progestin Regimens on Heart Disease Risk Factors in Postmenopausal Women: The Postmenopausal Estrogen/Progestin Interventions (PEPI) TrialJAMA, 273
N. Miller, C. Rice-evans, Michael Davies, Vimala Gopinathan, A. Milner (1993)
A novel method for measuring antioxidant capacity and its application to monitoring the antioxidant status in premature neonates.Clinical science, 84 4
M. Pepys, A. Berger (2001)
The renaissance of C reactive proteinBMJ : British Medical Journal, 322
D. Herrington, D. Reboussin, K. Brosnihan, P. Sharp, S. Shumaker, Thomas Snyder, C. Furberg, Glen Kowalchuk, T. Stuckey, W. Rogers, David Givens, D. Waters (2000)
Effects of estrogen replacement on the progression of coronary-artery atherosclerosis.The New England journal of medicine, 343 8
O. Ylikorkala, Bruno Cacciatore, Ilari Paakkari, Matti Tikkanen, L. Viinikka, J. Toivonen (1998)
The long-term effects of oral and transdermal postmenopausal hormone replacement therapy on nitric oxide, endothelin-1, prostacyclin, and thromboxane.Fertility and sterility, 69 5
W. Friedewald, R. Levy, D. Fredrickson (1972)
Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge.Clinical chemistry, 18 6
D. Mikhailidis, E. Ganotakis, K. Spyropoulos, I. Jagroop, D. Byrne, A. Winder (1998)
Prothrombotic and lipoprotein variables in patients attending a cardiovascular risk management clinic: response to ciprofibrate or lifestyle advice.International angiology : a journal of the International Union of Angiology, 17 4
P. Collins, J. Shay, C. Jiang, J. Moss (1994)
Nitric oxide accounts for dose-dependent estrogen-mediated coronary relaxation after acute estrogen withdrawal.Circulation, 90 4
Ingrid Os, A. Hofstad, M. Brekke, Michael Abdelnoor, B. Nesheim, Anne Jacobsen, K. Birkeland, Åsmund Larsen, K. Midtbø, Arne Westheim (2000)
The EWA (Estrogen in Women with Atherosclerosis) Study: a randomized study of the use of hormone replacement therapy in women with angiographically verified coronary artery disease. Characteristics of the study population. Effects on lipids and lipoproteinsJournal of Internal Medicine, 247
Walsh (2000)
The effects of raloxifene compared with hormone replacement therapy on homocysteine and C-reactive protein in healthy postmenopausal womenJ Clin Endocrinol Metabol, 85
E. Farish, J. Barnes, H. Rolton, K. Spowart, C. Fletcher, D. Hart (1994)
Effects of tibolone on lipoprotein(a) and HDL subfractions.Maturitas, 20 2-3
Bush (1987)
Cardiovascular mortality and non-contraceptive estrogen use in womenCirculation, 75
John Wilcox, Ilene Hatch, E. Gentzschein, F. Stanczyk, Rogerio Lobo (1997)
Endothelin levels decrease after oral and nonoral estrogen in postmenopausal women with increased cardiovascular risk factors.Fertility and sterility, 67 2
C. Castelo-Branco, E. Casals, F. Figueras, A. Sanjuán, J. Vicente, J. Balasch, J. Vanrell (1999)
Two-year prospective and comparative study on the effects of tibolone on lipid pattern, behavior of apolipoproteins AI and B.Menopause, 6 2
M. Milner, M. Sinnott, Tommy Cooke, A. Kelly, T. McGill, R. Harrison (1996)
A 2‐year Study of Lipid and Lipoprotein Changes in Postmenopausal Women With Tibolone and Estrogen‐ProgestinObstetrics & Gynecology, 87
M. Stampfer, G. Colditz (1991)
Estrogen replacement therapy and coronary heart disease: A quantitative assessment of the epidemiologic evidence☆☆☆Preventive Medicine, 20
S. Marcovina, G. Lippi, G. Guidi (1995)
Lipoprotein(a) immunoassays: comparison of a semi-quantitative latex method and two monoclonal enzyme immunoassaysInternational Journal of Clinical and Laboratory Research, 25
P. Ridker, C. Hennekens, N. Rifai, Julie Buring, J. Manson (1999)
Hormone replacement therapy and increased plasma concentration of C-reactive protein.Circulation, 100 7
R. Ross, A. Paganini-Hill (1983)
Estrogen Replacement Therapy and Coronary Heart DiseaseSeminars in Reproductive Endocrinology, 1
T. Strandberg, R. Tilvis (2000)
C-reactive protein, cardiovascular risk factors, and mortality in a prospective study in the elderly.Arteriosclerosis, thrombosis, and vascular biology, 20 4
P. Ridker, C. Hennekens, Julie Buring, N. Rifai (2000)
C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women.The New England journal of medicine, 342 12
Nader Rifai, P. Ridker, P. Ridker (2001)
Proposed cardiovascular risk assessment algorithm using high-sensitivity C-reactive protein and lipid screening.Clinical chemistry, 47 1
L. Sargeant, N. Wareham, K. Khaw (2000)
Hormone replacement therapy and glucose tolerance in EPIC‐Norfolk: a population‐based studyDiabetes/Metabolism Research and Reviews, 16
Paul Hardiman, P. Nihoyannopoulos, P. Kicovic, Jean Ginsburg (1991)
Cardiovascular effects of Org OD 14--a new steroidal therapy for climacteric symptoms.Maturitas, 13 3
Mikhailidis (1998)
Prothrombotic and lipoprotein variables in patients attending a cardiovascular risk management clinicInt Angiol, 17
N. Nago, K. Kayaba, Jun Hiraoka, Hitoshi Matsuo, T. Goto, K. Kario, Akizumi Tsutsumi, Y. Nakamura, M. Igarashi (1995)
Lipoprotein(a) levels in the Japanese population: influence of age and sex, and relation to atherosclerotic risk factors. The Jichi Medical School Cohort Study.American journal of epidemiology, 141 9
Ginsburg (2000)
The place of tibolone in menopausal therapy
P. Zandberg, J. Peters, P. Demacker, E. Reeder, M. Smit, D. Meuleman (2001)
Comparison of the antiatherosclerotic effect of tibolone with that of estradiol and ethinyl estradiol in cholesterol-fed, ovariectomized rabbitsMenopause, 8
A. Davies, S. Stone, D. Kidd, J. Macmahon (1995)
Pharyngeal sensation and gag reflex in healthy subjectsThe Lancet, 345
H. Brussaard, J. Leuven, M. Frölich, C. Kluft, H. Krans (1997)
Short-term oestrogen replacement therapy improves insulin resistance, lipids and fibrinolysis in postmenopausal women with NIDDMDiabetologia, 40
E. Erlandsen, E. Randers (2000)
Reference interval for serum C-reactive protein in healthy blood donors using the Dade Behring N Latex CRP mono assay.Scandinavian journal of clinical and laboratory investigation, 60 1
J. Sullivan, R. Zwaag, G. Lemp, J. Hughes, V. Maddock, F. Kroetz, K. Ramanathan, D. Mirvis (1988)
Postmenopausal estrogen use and coronary atherosclerosis.Annals of internal medicine, 108 3
R. Tracy, R. Lemaitre, B. Psaty, D. Ives, R. Evans, M. Cushman, E. Meilahn, L. Kuller (1997)
Relationship of C-reactive protein to risk of cardiovascular disease in the elderly. Results from the Cardiovascular Health Study and the Rural Health Promotion Project.Arteriosclerosis, thrombosis, and vascular biology, 17 6
D. Crook, M. Cust, K. Gangar, M. Worthington, T. Hillard, J. Stevenson, M. Whitehead, V. Wynn (1992)
Comparison of transdermal and oral estrogen-progestin replacement therapy: effects on serum lipids and lipoproteins.American journal of obstetrics and gynecology, 166 3
R. Mangiafico, L. Malatino, M. Santonocito, R. Spada (1998)
Plasma endothelin-1 concentrations in non-insulin-dependent diabetes mellitus and nondiabetic patients with chronic arterial obstructive disease of the lower limbs.International angiology : a journal of the International Union of Angiology, 17 2
N. Sattar, M. Perera, M. Small, M. Lumsden (1999)
Hormone replacement therapy and sensitive C-reactive protein concentrations in women with type-2 diabetesThe Lancet, 354
Herrington (2000)
Effects of estrogen replacement on the progression of coronary-artery atherosclerosisN Engl J Med, 343
W. Hänggi, K. Lippuner, W. Riesen, P. Jaeger, M. Birkhauser (1997)
Long term influence of different postmenopausal hormone replacement regimens on serum lipids and lipoprotein(a): a randomised studyBJOG: An International Journal of Obstetrics & Gynaecology, 104
H. Gruchow, A. Anderson, J. Barboriak, K. Sobocinski (1988)
Postmenopausal use of estrogen and occlusion of coronary arteries.American heart journal, 115 5
Os (2000)
The EWA (Estrogen in Women with Atherosclerosis) studyIntern Med, 247
S. Hulley, D. Grady, T. Bush, C. Furberg, D. Herrington, B. Riggs, E. Vittinghoff (1998)
Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. Heart and Estrogen/progestin Replacement Study (HERS) Research Group.JAMA, 280 7
Brian Walsh, S. Paul, Robert Wild, Robert Dean, Russell Tracy, David Cox, Pamela Anderson (2000)
The effects of hormone replacement therapy and raloxifene on C-reactive protein and homocysteine in healthy postmenopausal women: a randomized, controlled trial.The Journal of clinical endocrinology and metabolism, 85 1
Fertility and Sterility – Unpaywall
Published: May 1, 2002
Access the full text.
Sign up today, get DeepDyve free for 14 days.